AIRLINK 214.00 Increased By ▲ 4.45 (2.12%)
BOP 10.39 Decreased By ▼ -0.07 (-0.67%)
CNERGY 7.29 Decreased By ▼ -0.06 (-0.82%)
FCCL 34.30 Decreased By ▼ -0.09 (-0.26%)
FFL 18.45 Increased By ▲ 0.40 (2.22%)
FLYNG 23.20 Increased By ▲ 0.28 (1.22%)
HUBC 130.99 Decreased By ▼ -1.50 (-1.13%)
HUMNL 14.30 Increased By ▲ 0.16 (1.13%)
KEL 5.07 Increased By ▲ 0.04 (0.8%)
KOSM 7.21 Increased By ▲ 0.14 (1.98%)
MLCF 45.10 Decreased By ▼ -0.10 (-0.22%)
OGDC 219.15 Increased By ▲ 0.77 (0.35%)
PACE 7.70 Increased By ▲ 0.12 (1.58%)
PAEL 42.20 Increased By ▲ 0.50 (1.2%)
PIAHCLA 17.47 Increased By ▲ 0.17 (0.98%)
PIBTL 8.70 Increased By ▲ 0.15 (1.75%)
POWERPS 12.50 No Change ▼ 0.00 (0%)
PPL 188.44 Decreased By ▼ -0.59 (-0.31%)
PRL 42.19 Decreased By ▼ -0.14 (-0.33%)
PTC 25.50 Increased By ▲ 0.33 (1.31%)
SEARL 103.90 Decreased By ▼ -0.06 (-0.06%)
SILK 1.05 Increased By ▲ 0.02 (1.94%)
SSGC 40.75 Increased By ▲ 1.51 (3.85%)
SYM 19.35 Increased By ▲ 0.19 (0.99%)
TELE 9.32 Increased By ▲ 0.08 (0.87%)
TPLP 12.80 Decreased By ▼ -0.30 (-2.29%)
TRG 69.56 Increased By ▲ 0.38 (0.55%)
WAVESAPP 10.69 Decreased By ▼ -0.03 (-0.28%)
WTL 1.71 No Change ▼ 0.00 (0%)
YOUW 4.22 Increased By ▲ 0.08 (1.93%)
BR100 12,143 Increased By 63.4 (0.52%)
BR30 36,712 Increased By 109.7 (0.3%)
KSE100 116,630 Increased By 576.9 (0.5%)
KSE30 36,753 Increased By 175.1 (0.48%)

The Bioequivalence Study Centre (BeSt Centre) of University of Veterinary and Animal Sciences (UVAS), Lahore has been granted approval by the Ministry of Health, Pakistan. The centre is well equipped with all the high-tech facilities and trained manpower, needed to carryout such studies according to the international standards.
Expressing his views, vice-chancellor UVAS and head of BeSt Center, Dr Muhammad Nawaz said the approval marks milestone in the history of evolution of research and development as well as regulatory process in the pharmaceutical sector of Pakistan.
It also provides solutions to the issues of quality, price and cost effectiveness of the pharmaceuticals manufactured in Pakistan. The approval will pave way for production of cost effective drugs and medicines supplies to our public and private sector health facilities, he added.

Copyright Business Recorder, 2010

Comments

Comments are closed.